Pharma news: PhRMA: 258 Vaccines in Clinical Development

Science 

 19 August 2016. An industry group of American pharmaceutical makers says its companies have 258 vaccines, including immunotherapies, in clinical trials or awaiting FDA approval. The report, issued today by Pharmaceutical Research and Manufacturers of America, or PhRMA, covers preventive vaccines against infectious disorders, as well as disease treatments that harness the body’s immune system....

partial ovarian cancer/solid tumors -  (click on 'report' for full list)

 AE-O vaccine
Antigen Express
ovarian cancer
Phase I
(peptide vaccine)
Wellesley, MA
www.antigenexpress.com

BriaVax™
BriaCell Therapeutics
ovarian cancer
Phase I
SV-BR 1 GM cancer vaccine
Berkeley, CA
www.briacell.com

cancer immunotherapy
AiVita Biomedical
ovarian cancer
Phase II
(ovarian cancer stem cell therapy)
Irvine, CA
www.aivitabiomedical.com

CDX-1401
gynecological cancers
Phase I/II
www.celldex.com

CMB 305
ORPHAN DRUG
solid cancers expressing NY-ESO-1
Phase I
www.immunedesign.com